Verified· 2 sources

Cabaletta Bio GmbH

Summary

About the company

Cabaletta Bio GmbH is a clinical‑stage biotechnology company developing engineered T cell therapies for autoimmune diseases. It applies the Cabaletta Approach to B cell Ablation (CABA®) platform and is advancing rese‑cel, a fully human CD19‑CAR T candidate, in RESET™ Phase 1/2 trials to evaluate transient B‑cell depletion as a means to reset the immune system in conditions such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis and pemphigus vulgaris.

AI-generated

Offering

Products & services

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Cabaletta Bio GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

Cabaletta Bio GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Cabaletta Bio GmbH in comparison

Industry comparisons are coming soon

Similar companies